Here's our list of the leaders in Massachusetts tech, biotech and climate tech who aren't just surviving, but moving their ...

One such contender is Syntis Bio, a Boston-based biotech firm working on an oral medication designed to replicate the effects of gastric bypass surgery without the need for invasive procedures.

and a wonderful example of the power of biotechnology to protect species, both extant and extinct.” Drew Weisholtz is a reporter for TODAY Digital, focusing on pop culture, nostalgia and ...

AmplifyBio, once one of central Ohio's most promising biotech firms, announced Friday that it has shut down. In a posting on its website, the company said the decision followed months of efforts ...

Trinity Biotech (TRIB) has obtained an additional $4M in debt financing from its primary lender, Perceptive Advisors. The additional liquidity will support both the continued development of ...

A San Francisco biotech company said Wednesday that it has developed an antiaging pill for dogs that might be able to help extend the life of your furry friend. It can be prescribed for canines ...

Although a federal judge has temporarily blocked the policy change, government grants to early-stage biotech startups could still face delays or be eliminated entirely, said Chris Gibson ...

The commonwealth’s biotechnology and innovation footprint is expanding, thanks to an award from the state’s GO Virginia economic development program and a close partnership between the University of ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

The intersection of artificial intelligence (AI) and biotechnology is revolutionizing the healthcare landscape, offering opportunities for venture capitalists (VCs) to drive innovation and achieve ...

Two years ago, Incendia Therapeutics, a biotechnology company specializing in cancer-related research, moved into Allston in a building along the Massachusetts Turnpike. Incendia, along with ...

While it tends to fly under the radar for many people, the biotech industry has seen a resurgence in investor interest over the last couple of years. While there could be several reasons for this ...